668 related articles for article (PubMed ID: 27955666)
1. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
[TBL] [Abstract][Full Text] [Related]
2. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
[TBL] [Abstract][Full Text] [Related]
3. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
Lau KL; Yim PH
East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
[TBL] [Abstract][Full Text] [Related]
4. Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
Nord J Psychiatry; 2016 Aug; 70(6):450-5. PubMed ID: 27049594
[TBL] [Abstract][Full Text] [Related]
5. Lithium and clozapine-induced neutropenia/agranulocytosis.
Blier P; Slater S; Measham T; Koch M; Wiviott G
Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
[TBL] [Abstract][Full Text] [Related]
7. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland.
Rubio JM; Kane JM; Tanskanen A; Tiihonen J; Taipale H
Lancet Psychiatry; 2024 Jun; 11(6):443-450. PubMed ID: 38697177
[TBL] [Abstract][Full Text] [Related]
8. Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
Nord J Psychiatry; 2017 Oct; 71(7):496-502. PubMed ID: 28632422
[TBL] [Abstract][Full Text] [Related]
9. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
Vila-Rodriguez F; Tsang P; Barr AM
Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
[No Abstract] [Full Text] [Related]
10. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
Maskasame S; Krisanaprakornkit T; Khiewyoo J
J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
[TBL] [Abstract][Full Text] [Related]
11. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
12. Haematological side effects of clozapine: patient characteristics.
Miller PR; Cutten AE
N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
[TBL] [Abstract][Full Text] [Related]
13. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
Simon L; Cazard F
Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
[TBL] [Abstract][Full Text] [Related]
14. A follow-up study of a population of schizophrenic patients treated with clozapine.
Bourin M; Guitton B; Dailly E; Hery P; Jolliet P
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Nov; 25(8):1481-95. PubMed ID: 11642649
[TBL] [Abstract][Full Text] [Related]
15. Clozapine, agranulocytosis, and benign ethnic neutropenia.
Rajagopal S
Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
[No Abstract] [Full Text] [Related]
16. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
17. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
18. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective.
Legge SE; Walters JT
Pharmacogenomics; 2019 Mar; 20(4):279-290. PubMed ID: 30767710
[TBL] [Abstract][Full Text] [Related]
19. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
[No Abstract] [Full Text] [Related]
20. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.
Munro J; O'Sullivan D; Andrews C; Arana A; Mortimer A; Kerwin R
Br J Psychiatry; 1999 Dec; 175():576-80. PubMed ID: 10789357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
